Real-world treatment patterns for patients receiving second-line and third-line treatment for advanced non-small cell lung cancer: a systematic review of recently …
J Davies, M Patel, C Gridelli, F de Marinis… - PLoS …, 2017 - journals.plos.org
Most patients with advanced non-small cell lung cancer (NSCLC) have a poor prognosis
and receive limited benefit from conventional treatments, especially in later lines of therapy …
and receive limited benefit from conventional treatments, especially in later lines of therapy …
[HTML][HTML] High tumor burden in non-small-cell lung cancer: A review of the literature
L Cabezón-Gutiérrez, M Sereno… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
Methods: A non-systematic literature review was conducted. We searched for eligible
randomized controlled trials from PubMed, EMBASE, and the Cochrane Central Register of …
randomized controlled trials from PubMed, EMBASE, and the Cochrane Central Register of …
Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology …
AP Abernethy, A Arunachalam, T Burke, C McKay… - PloS one, 2017 - journals.plos.org
Purpose To establish a baseline for care and overall survival (OS) based upon
contemporary first-line treatments prescribed in the era before the introduction of immune …
contemporary first-line treatments prescribed in the era before the introduction of immune …
[HTML][HTML] Non-interventional LUME-BioNIS study of nintedanib plus docetaxel after chemotherapy in adenocarcinoma non-small cell lung cancer: a subgroup analysis …
M Reck, K Syrigos, S Miliauskas, S Zöchbauer-Müller… - Lung Cancer, 2020 - Elsevier
Objectives To evaluate the effectiveness and safety of nintedanib plus docetaxel in patients
with advanced adenocarcinoma non-small cell lung cancer (NSCLC) previously treated with …
with advanced adenocarcinoma non-small cell lung cancer (NSCLC) previously treated with …
125I brachytherapy in locally advanced nonsmall cell lung cancer after progression of concurrent radiochemotherapy
Z Xiang, G Li, Z Liu, J Huang, Z Zhong, L Sun, C Li… - Medicine, 2015 - journals.lww.com
125I Brachytherapy in Locally Advanced Nonsmall Cell Lung Ca... : Medicine 125I
Brachytherapy in Locally Advanced Nonsmall Cell Lung Cancer After Progression of …
Brachytherapy in Locally Advanced Nonsmall Cell Lung Cancer After Progression of …
BRAFV600E-mutant metastatic NSCLC: disease overview and treatment landscape
D Planchard, RE Sanborn, MV Negrao… - NPJ Precision …, 2024 - nature.com
In this review, we cover the current understanding of BRAF mutations and associated clinical
characteristics in patients with metastatic NSCLC, approved and emerging treatment …
characteristics in patients with metastatic NSCLC, approved and emerging treatment …
Biological and prognostic significance of the morphological types and vascular patterns in colorectal liver metastases (CRLM): looking beyond the tumor margin
PN Siriwardana, TV Luong, J Watkins, H Turley… - Medicine, 2016 - journals.lww.com
Patients with encapsulated colorectal liver metastases (CRLM) have a better prognosis than
those without a capsule. The reason for the encapsulation is unknown. Hypoxia inducible …
those without a capsule. The reason for the encapsulation is unknown. Hypoxia inducible …
Defining aggressive or early progressing nononcogene-addicted non-small-cell lung cancer: a separate disease entity?
M Reck, KM Kerr, C Grohé, C Manegold… - Future …, 2019 - Taylor & Francis
A substantial proportion of patients with nononcogene-addicted non-small-cell lung cancer
(NSCLC) has 'aggressive disease', as reflected in short time to progression or lack of …
(NSCLC) has 'aggressive disease', as reflected in short time to progression or lack of …
125I brachytherapy of locally advanced non-small-cell lung cancer after one cycle of first-line chemotherapy: a comparison with best supportive care
J Song, X Fan, Z Zhao, M Chen, W Chen… - OncoTargets and …, 2017 - Taylor & Francis
Objectives The objective of this study was to assess the efficacy of computed tomography
(CT)-guided 125I brachytherapy alone in improving the survival and quality of life of patients …
(CT)-guided 125I brachytherapy alone in improving the survival and quality of life of patients …
Treatment patterns for advanced non–small-cell lung cancer after platinum-containing therapy in US community oncology clinical practice
C McKay, T Burke, X Cao, AP Abernethy… - Clinical Lung Cancer, 2016 - Elsevier
Background Knowledge of the real-world treatment patterns for non–small-cell lung cancer
(NSCLC) can identify quality-of-care gaps and guide resource allocation needs. Our …
(NSCLC) can identify quality-of-care gaps and guide resource allocation needs. Our …